Homo- and hetero-oligomerization of G protein-coupled receptors

Life Sciences

Volumn 74, Issue 2-3, 2003, Pages 173-180

  Lee, Samuel P ^a   O'Dowd, Brian F ^a,b   George, Susan R ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dimerization; Dopamine receptor; G protein coupled receptor; Oligomerization; Opioid receptor; Serotonin receptor

Indexed keywords

DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; OPIATE RECEPTOR; RHODOPSIN; SEROTONIN RECEPTOR;

CONFERENCE PAPER; HUMAN; MOLECULAR MODEL; NONHUMAN; OLIGOMERIZATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

HOMO;

EID: 0242289624     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.09.028     Document Type: Conference Paper

References (26)

1. Benkirane M., Jin D.Y., Chun R.F., Koup R.A., Jeang K.T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32. Journal of Biological Chemistry. 272(49):1997;30603-30606.
2. Bockaert J., Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO Journal. 18(7):1999;1723-1729.
3. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2(4):2001;274-286.
4. Casey J.R., Reithmeier R.A. Detergent interaction with band 3, a model polytopic membrane protein. Biochemistry. 32(4):1993;1172-1179.
5. Davies A., Gowen B.E., Krebs A.M., Schertler G.F., Saibil H.R. Three-dimensional structure of an invertebrate rhodopsin and basis for ordered alignment in the photoreceptor membrane. Journal of Molecular Biology. 314(3):2001;455-463.
6. Elmhurst J.L., Xie Z., O'Dowd B.F., George S.R. The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization. Brain Research Molecular Brain Research. 80(1):2000;63-74.
7. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., Palczewski K. Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature. 421(6919):2003;127-128.
8. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. Journal of Biological Chemistry. 275(34):2000;26128- 26135.
9. George S.R., Lee S.P., Varghese G., Zeman P.R., Seeman P., Ng G.Y.K., O'Dowd B.F. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. Journal of Biological Chemistry. 273(46):1998;30244-30248.
10. George S.R., O'Dowd B.F., Lee S.P. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nature Reviews Drug Discovery. 1(10):2002;808-820.
11. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocrine Reviews. 21(1):2000;90-113.
12. Guo W., Shi L., Javitch J.A. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. Journal of Biological Chemistry. 278(7):2003;4385-4388.
13. Hebert T.E., Moffett S., Morello J.P., Loisel T.P., Bichet D.G., Barret C., Bouvier M. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. Journal of Biological Chemistry. 271(27):1996;16384-16392.
14. Hill B.C., Cook K., Robinson N.C. Subunit dissociation and protein unfolding in the bovine heart cytochrome oxidase complex induced by guanidine hydrochloride. Biochemistry. 27(13):1988;4741-4747.
15. Karpa K.D., Lin R., Kabbani N., Levenson R. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Molecular Pharmacology. 58(4):2000;677-683.
16. Lee S.P., O'Dowd B.F., Ng G.Y., Varghese G., Akil H., Mansour A., Nguyen T., George S.R. Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Molecular Pharmacology. 58(1):2000;120-128.
17. Lee S.P., O'Dowd B.F., Rajaram R., Nguyen T., George S.R. D2 dopamine receptor homodimerization is mediated by multiple sites of interaction including an intermolecular interaction involving transmembrane domain 4. Biochemistry. 42(37):2003;11023-11031.
18. Levac B.A., O'Dowd B.F., George S.R. Oligomerization of opioid receptors: generation of novel signaling units. Current Opinion in Pharmacology. 2(1):2002;76-81.
19. Liang Y., Fotiadis D., Filipek S., Saperstein D.A., Palczewski K., Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. Journal of Biological Chemistry. 278(24):2003;21655-21662.
20. Nimchinsky E.A., Hof P.R., Janssen W.G., Morrison J.H., Schmauss C. Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. Journal of Biological Chemistry. 272:1997;29229-29237.
21. Nozais M., Bechet J.J., Houadjeto M. Inactivation, subunit dissociation, aggregation, and unfolding of myosin subfragment 1 during guanidine denaturation. Biochemistry. 31(4):1992;1210-1215.
22. Ramjeesingh M., Huan L.J., Garami E., Bear C.E. Novel method for evaluation of the oligomeric structure of membrane proteins. Biochemical Journal. 342(Pt 1):1999;119-123.
23. Schoneberg T., Yun J., Wenkert D., Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO Journal. 15(6):1996;1283-1291.
24. Schulz A., Grosse R., Schultz G., Gudermann T., Schoneberg T. Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors. Journal of Biological Chemistry. 275(4):2000;2381-2389.
25. Xie Z., Lee S.P., O'Dowd B.F., George S.R. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Letters. 456(1):1999;63-67.
26. Zhu X., Wess J. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry. 37(45):1998;15773- 15784.